Monalizumab, CAS [[1228763-95-8]]

Catalog Number: TGM-T76691
Article Name: Monalizumab, CAS [[1228763-95-8]]
Biozol Catalog Number: TGM-T76691
Supplier Catalog Number: T76691
Alternative Catalog Number: TGM-T76691-1MG,TGM-T76691-5MG,TGM-T76691-10MG
Manufacturer: TargetMol
Category: Biochemikalien
Monalizumab is a novel immune checkpoint inhibitor targeting natural killer cell population 2A (NKG2A). Monalizumab is a humanized monoclonal antibody against NKG2A that induces IFN-gamma production, thereby activating natural killer cell function. Monalizumab has antitumor activity and can be used to study neck squamous cell carcinoma (HNSCC).
Purity: >95%
CAS Number: [1228763-95-8]
Target: Chk|||IFNAR